ABCL:NASDAQ
AbCellera Biologics Inc
$13.06
arrow_downward
-0.68%(-0.090) 1D
Oct 7, 9:49:02 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABCL...
Open
$12.85
High
$13.01
Low
$12.56
Mkt. cap
4.14B
Avg. vol.
5.09M
Volume
337.63K
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
Open
$12.85
High
$13.01
Low
$12.56
Mkt. cap
4.14B
Avg. vol.
5.09M
Volume
337.63K
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
News stories
From web sources and news partners
TipRanks
·
22 hours ago
Why AbCellera’s Hot Stock Is Suddenly Sinking
https://www.dars.gov.et/
·
1 month ago
ABCL Q2 2026 Earnings: Wider-than-Expected Loss Weighs on Shares - Capex Guidance
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com